Tocilizumab biosimilar (Livzon Group) | m-entrepreneurship.com

Product Name :
Tocilizumab biosimilar (Livzon Group)

Search keywords :
Oncostatin M

drugId :
null

Target Vo:
Interleukin-6 receptor alpha subunit

Target Vo Short Name :
IL6RA

Moa_Name:
Interleukin-6 receptor alpha subunit antagonists

First Approval Country :
Mainland China

First Approval Date Filter:
2023

Origin Company_Name :
Livzon Pharmaceutical Group Inc

Active Company_Name :
Livzon Mabpharm Inc

Active Indication_Name:
Arthritis, Rheumatoid

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Retinoic Acid Receptor alpha Antibody
Hsp60 Antibody (YA730)
IL-10 Antibody: IL-10 Antibody is an unconjugated, approximately 18 kDa, rabbit-derived, anti-IL-10 polyclonal antibody. IL-10 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, chicken, pig, rabbit, sheep, guinea pig background without labeling.

Author: Betaine hydrochloride

Related Posts